Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect

References

• ChanJKCheungMKHusainAPatterns and progress in ovarian cancer over 14 yearsObstet Gynecol20061083 Pt 152152816946210
   PubMed Web of Science ®Google Scholar
• JelovacDArmstrongDKRecent progress in the diagnosis and treatment of ovarian cancerCA Cancer J Clin201161318320321521830
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statisticsCA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• CristeaMHanESalmonLMorganRJPractical considerations in ovarian cancer chemotherapyTher Adv Med Oncol20102317518721789133
   PubMedGoogle Scholar
• VaseyPAJaysonGCGordonAScottish Gynaecological Cancer Trials GroupPhase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinomaJ Natl Cancer Inst200496221682169115547181
   PubMed Web of Science ®Google Scholar
• PignataSScambiaGFerrandinaGCarboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trialJ Clin Oncol201129273628363521844495
   PubMed Web of Science ®Google Scholar
• WrightJDHouJYBurkeWMUtilization and toxicity of alternative delivery methods of adjuvant chemotherapy for ovarian cancerObstet Gynecol2016127698599127159764
   PubMed Web of Science ®Google Scholar
• WenzelLBHuangHQArmstrongDKWalkerJLCellaDGynecologic Oncology GroupHealth-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group StudyJ Clin Oncol200725443744317264340
   PubMed Web of Science ®Google Scholar
• BristowREChangJZiogasACamposBChavezLRAnton-CulverHImpact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survivalJ Am Coll Surg2015220594095025840536
   PubMed Web of Science ®Google Scholar
• GeRTanESharghi-NaminiSAsadaHHExosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers?Cancer Microenviron20125332333222585423
   PubMedGoogle Scholar
• KogaKMatsumotoKAkiyoshiTPurification, characterization and biological significance of tumor-derived exosomesAnticancer Res2005256A3703370716302729
   PubMed Web of Science ®Google Scholar
• KellerSSandersonMPStoeckAAltevogtPExosomes: from biogenesis and secretion to biological functionImmunol Lett2006107210210817067686
   PubMed Web of Science ®Google Scholar
• van NielGPorto-CarreiroISimoesSRaposoGExosomes: a common pathway for a specialized functionJ Biochem20061401132116877764
   PubMed Web of Science ®Google Scholar
• SimonsMRaposoGExosomes – vesicular carriers for intercellular communicationCurr Opin Cell Biol200921457558119442504
   PubMed Web of Science ®Google Scholar
• MasyukAIMasyukTVLarussoNFExosomes in the pathogenesis, diagnostics, and therapeutics of liver diseasesJ Hepatol201359362162523557871
   PubMed Web of Science ®Google Scholar
• BeachAZhangHGRatajczakMZKakarSSExosomes: an overview of biogenesis, composition and role in ovarian cancerJ Ovarian Res201471424460816
   PubMed Web of Science ®Google Scholar
• RakJYuJLKlementGKerbelRSOncogenes and angiogenesis: signaling three-dimensional tumor growthJ Investig Dermatol Symp Proc2000512433
   Google Scholar
• ValentiRHuberVIeroMFilipazziPParmianiGRivoltiniLTumor-released microvesicles as vehicles of immunosuppressionCancer Res20076772912291517409393
   PubMed Web of Science ®Google Scholar
• PsailaBLydenDThe metastatic niche: adapting the foreign soilNat Rev Cancer20099428529319308068
   PubMed Web of Science ®Google Scholar
• PanBTJohnstoneRMFate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptorCell19833339679786307529
   PubMed Web of Science ®Google Scholar
• DavelooseDWolfCJeanguillaumeCLeterrierFFabreGBereziatGInhibitory effect of microvesicles collected from stored blood on platelet aggregationThromb Res1981221–21952017292439
   PubMed Web of Science ®Google Scholar
• ThéryCZitvogelLAmigorenaSExosomes: composition, biogenesis and functionNat Rev Immunol20022856957912154376
   PubMed Web of Science ®Google Scholar
• StoorvogelWKleijmeerMJGeuzeHJRaposoGThe biogenesis and functions of exosomesTraffic20023532133011967126
   PubMed Web of Science ®Google Scholar
• BobrieAColomboMRaposoGThéryCExosomes secretion: molecular mechanisms and roles in immune responseTraffic201112121659166821645191
   PubMed Web of Science ®Google Scholar
• RaposoGNijmanHWStoorvogelWB lymphocytes secrete antigen-presenting vesiclesJ Exp Med19961833116111728642258
   PubMed Web of Science ®Google Scholar
• BlanchardNLankarDFaureFTCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complexJ Immunol200216873235324111907077
   PubMed Web of Science ®Google Scholar
• ThéryCRegnaultAGarinJMolecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73J Cell Biol1999147359961010545503
   PubMed Web of Science ®Google Scholar
• RaposoGTenzaDMecheriSPeronetRBonnerotCDesaymardCAccumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulationMol Biol Cell1997812263126459398681
   PubMed Web of Science ®Google Scholar
• LaiRCArslanFLeeMMExosome secreted by MSC reduces myocardial ischemia/reperfusion injuryStem Cell Res20104321422220138817
   PubMed Web of Science ®Google Scholar
• Van NielGMallegolJBevilacquaCIntestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in miceGut200352121690169714633944
   PubMed Web of Science ®Google Scholar
• HendersonMCAzorsaDOThe genomic and proteomic content of cancer cell-derived exosomesFront Oncol201223822649786
   PubMedGoogle Scholar
• ParkJETanHSDattaAHypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomesMol Cell Proteomics2010961085109920124223
   PubMed Web of Science ®Google Scholar
• KingHWMichaelMZGleadleJMHypoxic enhancement of exosome release by breast cancer cellsBMC Cancer20121242122998595
   PubMed Web of Science ®Google Scholar
• HedlundMNagaevaOKarglDBaranovVMincheva-NilssonLThermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cellsPLoS One201162e1689921364924
   PubMed Web of Science ®Google Scholar
• LogozziMDe MilitoALuginiLHigh levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patientsPLoS One200944e521919381331
   PubMed Web of Science ®Google Scholar
• AlmqvistNLönnqvistAHultkrantzSRaskCTelemoESerum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthmaImmunology20081251212718355242
   PubMed Web of Science ®Google Scholar
• RunzSKellerSRuppCMalignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAMGynecol Oncol2007107356357117900673
   PubMed Web of Science ®Google Scholar
• SamanSKimWRayaMExosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer diseaseJ Biol Chem201228763842384922057275
   PubMed Web of Science ®Google Scholar
• HegmansJPBardMPHemmesAProteomic analysis of exosomes secreted by human mesothelioma cellsAm J Pathol200416451807181515111327
   PubMed Web of Science ®Google Scholar
• SimpsonRJJensenSSLimJWProteomic profiling of exosomes: current perspectivesProteomics20088194083409918780348
   PubMed Web of Science ®Google Scholar
• SimpsonRJLimJWMoritzRLMathivananSExosomes: proteomic insights and diagnostic potentialExpert Rev Proteomics20096326728319489699
   PubMed Web of Science ®Google Scholar
• ZöllerMTetraspanins: push and pull in suppressing and promoting metastasisNat Rev Cancer200991405519078974
   PubMed Web of Science ®Google Scholar
• KellerSKönigAKMarméFSystemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomesCancer Lett20092781738119188015
   PubMed Web of Science ®Google Scholar
• PfefferSRTwo Rabs for exosomes releaseNat Cell Biol20101213420027197
   PubMed Web of Science ®Google Scholar
• McCreadyJSimsJDChanDJayDGSecretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activationBMC Cancer20101029420553606
   PubMed Web of Science ®Google Scholar
• TaylorDDZachariasWGercel-TaylorCExosome isolation for proteomic analyses and RNA profilingMethods Mol Biol201172823524621468952
   PubMedGoogle Scholar
• BryantRJPawlowskiTCattoJWChanges in circulating microRNA levels associated with prostate cancerBr J Cancer2012106476877422240788
   PubMed Web of Science ®Google Scholar
• TaftRJPangKCMercerTRDingerMMattickJSNon-coding RNAs: regulators of diseaseJ Pathol2010220212613919882673
   PubMed Web of Science ®Google Scholar
• HannafonBNDingWQIntercellular communication by exosome-derived microRNAs in cancerInt J Mol Sci2013147142401426923839094
   PubMed Web of Science ®Google Scholar
• ValadiHEkströmKBossiosASjöstrandMLeeJJLötvallJOExosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNat Cell Biol20079665465917486113
   PubMed Web of Science ®Google Scholar
• ThakurBKZhangHBeckerADouble-stranded DNA in exosomes: a novel biomarker in cancer detectionCell Res201424676676924710597
   PubMed Web of Science ®Google Scholar
• ThéryCAmigorenaSRaposoGClaytonAIsolation and characterization of exosomes from cell culture supernatants and biological fluidsCurr Protoc Cell Biol2006 Chapter 3:Unit 3.22
   PubMedGoogle Scholar
• ChoJAParkHLimEHExosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblastsGynecol Oncol2011123237938621903249
   PubMed Web of Science ®Google Scholar
• NakamuraKSawadaKKinoseYAbstract 5060: Exosome transfer from ovarian cancer cells to mesothelial cells promotes cell invasion by up regulating MMP-9 secretion and increasing clearance of mesothelial cellsCancer Res201575Suppl 155060
   Web of Science ®Google Scholar
• WangXZhaoXWangKWuLDuanTInteraction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitroCancer Sci2013104451652323347208
   PubMed Web of Science ®Google Scholar
• YingXWuQWuXEpithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophagesOncotarget2016728430764308727172798
   PubMedGoogle Scholar
• KanlikilicerPBayraktarRRashedMAbstract 1988: Exosome-mediated ovarian cancer tumorigenesis mediated by miR1246/Rb/Cav1 axisCancer Res201777Suppl 131988
   Web of Science ®Google Scholar
• XuYXuLZhengJGengLZhaoSMiR-101 inhibits ovarian carcinogenesis by repressing the expression of brain-derived neurotrophic factorFEBS Open Bio20177912581266
   Web of Science ®Google Scholar
• AndreolaGRivoltiniLCastelliCInduction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesiclesJ Exp Med2002195101303131612021310
   PubMed Web of Science ®Google Scholar
• LundholmMSchröderMNagaevaOProstate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasionPLoS One201499e10892525268476
   PubMed Web of Science ®Google Scholar
• ClaytonAMitchellJPCourtJLinnaneSMasonMDTabiZHuman tumor-derived exosomes down-modulate NKG2D expressionJ Immunol2008180117249725818490724
   PubMed Web of Science ®Google Scholar
• PengPYanYKengSExosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunityOncol Rep201125374976221181093
   PubMed Web of Science ®Google Scholar
• AbrahamsVMStraszewskiSLKamsteegMEpithelial ovarian cancer cells secrete functional Fas ligandCancer Res200363175573558114500397
   PubMed Web of Science ®Google Scholar
• MorelliAEThe immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantationAm J Transplant20066225426116426309
   PubMed Web of Science ®Google Scholar
• CzystowskaMSzajnikMRamjiKGrucaSStefanowiczANowisDAbstract 3975: Ovarian cancer cells release arginase-1-containing exosomes to suppress antitumor immune responseCancer Res201777Suppl 133975
   Web of Science ®Google Scholar
• XiangXPoliakovALiuCInduction of myeloid-derived suppressor cells by tumor exosomesInt J Cancer2009124112621263319235923
   PubMed Web of Science ®Google Scholar
• LiuYXiangXZhuangXContribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cellsAm J Pathol201017652490249920348242
   PubMed Web of Science ®Google Scholar
• SzajnikMCzystowskaMSzczepanskiMJMandapathilMWhitesideTLTumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg)PLoS One201057e1146920661468
   PubMed Web of Science ®Google Scholar
• BretzNPRidingerJRuppAKBody fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signalingJ Biol Chem201328851366913670224225954
   PubMed Web of Science ®Google Scholar
• WhitesideTLImmune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumor-derived exosomes)Biochem Soc Trans201341124525123356291
   PubMed Web of Science ®Google Scholar
• BobrieAThéryCExosomes and communication between tumours and the immune system: are all exosomes equal?Biochem Soc Trans201341126326723356294
   PubMed Web of Science ®Google Scholar
• WolfersJLozierARaposoGTumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingNat Med20017329730311231627
   PubMed Web of Science ®Google Scholar
• ZeelenbergISOstrowskiMKrumeichSTargeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responsesCancer Res20086841228123518281500
   PubMed Web of Science ®Google Scholar
• GastparRGehrmannMBauseroMAHeat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cellsCancer Res200565125238524715958569
   PubMed Web of Science ®Google Scholar
• LvLHWanYLLinYAnticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitroJ Biol Chem201228719158741588522396543
   PubMed Web of Science ®Google Scholar
• ElsnerLMuppalaVGehrmannMThe heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligandsJ Immunol200717985523553317911639
   PubMed Web of Science ®Google Scholar
• LiQLBuNYuYCHuaWXinXYExvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cell derived from umbilical cord blood for immunotherapy treatmentClin Med Oncol20082246146721892318
   PubMedGoogle Scholar
• CorcoranCRaniSO’BrienKDocetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesPLoS One2012712e5099923251413
   PubMed Web of Science ®Google Scholar
• JiRZhangBZhangXExosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancerCell Cycle201514152473248326091251
   PubMed Web of Science ®Google Scholar
• WeiYLaiXYuSExosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cellsBreast Cancer Res Treat2014147242343125007959
   PubMed Web of Science ®Google Scholar
• O’BrienKRaniSCorcoranCExosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cellsEur J Cancer20134981845185923453937
   PubMed Web of Science ®Google Scholar
• Au YeungCLCoNNTsurugaTExosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1Nat Commun201671115027021436
   PubMed Web of Science ®Google Scholar
• PinkRCSamuelPMassaDCaleyDPBrooksSACarterDRThe passenger strand miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cellsGynecol Oncol2015137114315125579119
   PubMed Web of Science ®Google Scholar
• Weiner-GorzelKDempseyEMilewskaMOverexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cellsCancer Med20154574575825684390
   PubMed Web of Science ®Google Scholar
• YanXYinJYaoHMaoNYangYPanLIncreased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancerCancer Res20107041616162420103635
   PubMed Web of Science ®Google Scholar
• YinJYanXYaoXSecretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patientsJ Cell Mol Med201216233734821435174
   PubMed Web of Science ®Google Scholar
• ZhangFFZhuYFZhaoQNMicrovesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistanceEur J Pharmacol2014738839024877693
   PubMed Web of Science ®Google Scholar
• SafaeiRLarsonBJChengTCAbnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cellsMol Cancer Ther20054101595160416227410
   PubMed Web of Science ®Google Scholar
• CrowJAtaySBanskotaSArtaleBSchmittSGodwinAKExosomes as mediators of platinum resistance in ovarian cancerOncotarget201787119171193628060758
   PubMedGoogle Scholar
• DonnellySRMossSEAnnexins in the secretory pathwayCell Mol Life Sci19975365335389230932
   PubMed Web of Science ®Google Scholar
• UedaKClarkDPChenCJRoninsonIBGottesmanMMPastanIThe human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiationJ Biol Chem198726225055083027054
   PubMed Web of Science ®Google Scholar
• VadlapatlaRKVadlapudiADPalDMitraAKMechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymesCurr Pham Des2013194071267140
   PubMed Web of Science ®Google Scholar
• LvMMZhuXYChenWXExosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoproteinTumour Biol20143511107731077925077924
   PubMedGoogle Scholar
• JeltschAJurkowskaRZNew concepts in DNA methylationTrends Biochem Sci201439731031824947342
   PubMed Web of Science ®Google Scholar
• CaoYLZhuangTXingBHLiNLiQExosomal DNMT1 mediates cisplatin resistance in ovarian cancerCell Biochem Funct201735629630328791708
   PubMed Web of Science ®Google Scholar
• MarchiniSFruscioRClivioLResistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancerEur J Cancer201349252053022897840
   PubMed Web of Science ®Google Scholar
• LatifiAAbubakerKCastrechiniNCisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profileJ Cell Biochem2011112102850286421618587
   PubMed Web of Science ®Google Scholar
• KurokawaMIseNOmiKGoishiKHigashiyamaSCisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changesCancer Sci2013104790491123566288
   PubMed Web of Science ®Google Scholar
• YewKHCrowJHirstJPressettoZGodwinAKEpimorphin-induced MET sensitizes ovarian cancer cells to platinumPLoS One201389e7263724039787
   PubMed Web of Science ®Google Scholar
• SzajnikMDerbisMLachMExosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapyGynecol Obstet (Sunnyvale)2013Suppl 4324466501
   PubMedGoogle Scholar
• LiJSherman-BaustCATsai-TurtonMBristowRERodenRBMorinPJClaudin-containing exosomes in the peripheral circulation of women with ovarian cancerBMC Cancer2009924419619303
   PubMed Web of Science ®Google Scholar
• BaylinSBJonesPAEpigenetic determinants of cancerCold Spring Harb Perspect Biol201689 pii: a019505
   PubMed Web of Science ®Google Scholar
• TaylorDDGercel-TaylorCMicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancerGynecol Oncol20081101132118589210
   PubMed Web of Science ®Google Scholar
• SvenssonKJKucharzewskaPChristiansonHCHypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cellsProc Natl Acad Sci U S A201110832131471315221788507
   PubMed Web of Science ®Google Scholar
• ParoliniIFedericiCRaggiCMicroenvironmental pH is a key factor for exosome traffic in tumor cellsJ Bio Chem200928449342113422219801663
   PubMed Web of Science ®Google Scholar
• FedericiCPetrucciFCaimiSExosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatinPLoS One201492e8819324516610
   PubMed Web of Science ®Google Scholar
• EscudierBDorvalTChaputNVaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trialJ Transl Med2005311015740633
   PubMed Web of Science ®Google Scholar
• ZhangJZhangHDYaoYFZhongSLZhaoJHTangJHβ-Elemene reverses chemoresistance of breast cancer cells by reducing resistance transmission via exosomesCell Physiol Biochem20153662274228626279432
   PubMedGoogle Scholar
• HuYLiDWuATWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNACancer Lett2017393606728216373
   PubMed Web of Science ®Google Scholar
• HuYQiuLHStudy on the mechanism of macrophages inhibiting epithelial ovarian cancer cell metastasis induced by TWEAK via exosomesProg Obstet Gynecol2015247512515 Chinese
   Google Scholar
• YueYWangXLiJHuangGRFanLAn experimental study on the construction of multifunctional exosome for treatment of ovarian cancerAnti-Tumor Pharm20177440641110.3969/j.issn.2095-1264.2017.04.05
   Google Scholar
• Mahmoodzadeh HosseiniHSoleimaniradJMehdizadeh AghdamEAminMImani FooladiAATexosome-anchored superantigen triggers apoptosis in original ovarian cancer cellsMed Oncol201532140925452173
   PubMed Web of Science ®Google Scholar
• NijmanHWvan DiestPJPoort-KeesomRJT cell infiltration and MHC I and II expression in the presence of tumor antigens: an immunohistochemical study in patients with serous epithelial ovarian cancerEur J Obstet Gynecol Reprod Biol200194111412011134836
   PubMed Web of Science ®Google Scholar
• AndreFSchartzNEMovassaghMMalignant effusions and immunogenic tumor-derived exosomesLancet2002360932929530512147373
   PubMed Web of Science ®Google Scholar
• NavabiHCrostonDHobotJPreparation of human ovarian cancer ascites-derived exosomes for a clinical trialBlood Cells Mol Dis200535214915216061407
   PubMed Web of Science ®Google Scholar